| Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis E Smagris, S BasuRay, J Li, Y Huang, KV Lai, J Gromada, JC Cohen, ... Hepatology 61 (1), 108-118, 2015 | 435 | 2015 |
| The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation S BasuRay, E Smagris, JC Cohen, HH Hobbs Hepatology 66 (4), 1111-1124, 2017 | 316 | 2017 |
| Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis S BasuRay, Y Wang, E Smagris, JC Cohen, HH Hobbs Proceedings of the National Academy of Sciences 116 (19), 9521-9526, 2019 | 293 | 2019 |
| Inactivation of Tm6sf2, a gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins E Smagris, S Gilyard, S BasuRay, JC Cohen, HH Hobbs Journal of Biological Chemistry 291 (20), 10659-10676, 2016 | 231 | 2016 |
| PNPLA3, CGI‐58, and inhibition of hepatic triglyceride hydrolysis in mice Y Wang, N Kory, S BasuRay, JC Cohen, HH Hobbs Hepatology 69 (6), 2427-2441, 2019 | 223 | 2019 |
| Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities JO Agola, PA Jim, HH Ward, S Basuray, A Wandinger‐Ness Clinical genetics 80 (4), 305-318, 2011 | 172 | 2011 |
| Rab7 mutants associated with Charcot-Marie-Tooth disease exhibit enhanced NGF-stimulated signaling S BasuRay, S Mukherjee, E Romero, MC Wilson, A Wandinger-Ness PloS one 5 (12), e15351, 2010 | 64 | 2010 |
| Rab7 mutants associated with Charcot-Marie-Tooth disease cause delayed growth factor receptor transport and altered endosomal and nuclear signaling S BasuRay, S Mukherjee, EG Romero, MNJ Seaman, A Wandinger-Ness Journal of Biological Chemistry 288 (2), 1135-1149, 2013 | 62 | 2013 |
| PNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease S Basu Ray Adipocyte 8 (1), 201-208, 2019 | 45 | 2019 |
| A Pan-GTPase inhibitor as a molecular probe L Hong, Y Guo, S BasuRay, JO Agola, E Romero, DS Simpson, ... PLoS One 10 (8), e0134317, 2015 | 43 | 2015 |
| Encapsulation and release of rifampicin using poly (vinyl pyrrolidone)-poly (methacrylic acid) polyelectrolyte capsules KNA Kumar, SB Ray, V Nagaraja, AM Raichur Materials Science and Engineering: C 29 (8), 2508-2513, 2009 | 39 | 2009 |
| Rapid parallel flow cytometry assays of active GTPases using effector beads T Buranda, S BasuRay, S Swanson, J Agola, V Bondu, ... Analytical biochemistry 442 (2), 149-157, 2013 | 29 | 2013 |
| Hepatocyte mARC1 promotes fatty liver disease LC Lewis, L Chen, LS Hameed, RR Kitchen, C Maroteau, SR Nagarajan, ... JHEP Reports 5 (5), 100693, 2023 | 28 | 2023 |
| A small molecule pan-inhibitor of Ras-superfamily GTPases with high efficacy towards Rab7 L Hong, P Simons, A Waller, J Strouse, Z Surviladze, O Ursu, C Bologa, ... Probe Reports from the NIH Molecular Libraries Program [Internet], 2013 | 17 | 2013 |
| RAB18 modulates autophagy in human stellate cells S BasuRay Journal of Clinical Lipidology 13 (5), 832-838, 2019 | 9 | 2019 |
| Rab7 in endocytosis and signaling S BasuRay, JO Agola, PA Jim, MN Seaman, A Wandinger-Ness, S Choi The Encyclopedia of Signaling Molecules, 1536-1547, 2012 | 6 | 2012 |
| Activated GTPase-based assays and kits for the diagnosis of sepsis and other infections T Buranda, JO Agola, S BasuRay, S Swanson, A Wandinger-Ness, ... US Patent 10,261,084, 2019 | 2 | 2019 |
| Rab7a: the master regulator of vesicular trafficking S BasuRay Biomedical Reviews 25, 67-81, 2014 | 2 | 2014 |
| Activated GTPase-based assays and kits for the diagnosis of sepsis and other infections T Buranda, JO Agola, S BasuRay, S Swanson, A Wandinger-Ness, ... US Patent 10,962,541, 2021 | 1 | 2021 |
| Genetik der nicht-alkoholischen Fettlebererkrankung M Krawczyk, F Lammert Adipositas-Ursachen, Folgeerkrankungen, Therapie 11 (01), 09-12, 2017 | 1 | 2017 |
